I'm don't post much on IHUB boards, When I do I try to be meaningful about it. I was reading some other biopharma stocks who were darlings whose stock price went up and up on hopes their clinical trials would prove the compounds are effective and didn't harm the participants (too much). I've read a lot of stories where the company stock price was slammed when a clinical trial didn't work out or harmed people. The good thing about LDN is that there have been many studies to show not only does it not harm it improves the lives of people who are suffering from HIV/immune disorders. I'm sold and think IMUN has a big chance to hit a HUGE home run. That's what I'm thinking about this company.
Market Data 
Markets 
AI
